JPX : 3341.T

NIHON CHOUZAI Co.,Ltd.

$3910 JPY

-$15 (-0.38%)

Volume
55.8K
Average Volume
50.82K
Market Capitalization
$116.82B
P/E Ratio
62.10
Dividend Yield
0.64%
Price Target
Year High
$23773364200.00
Year Low
$1314.00
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.33
Company Overview

JPX

Kazunori Ogi

Medical - Pharmaceuticals

Healthcare

3341.T

5864

JP

JPY

81 3 6810 0800

N/A

N/A

Liquidity Metrics

0.95

1.33

0.74

0.20

0.00

Sales & Valuation

$360.51B

0.41

1.95

0.00

0.00

Profitability

$46.54

$1.39B

0.67%

0.97%

3.16%

0.89%

P/E Metrics

62.10

-0.09

-0.09

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Financial Health Scores

2.81

5/9

$27.32B

$210.29B

$150.46B

$4.58B

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Toshiyuki Koyanagi Senior Executive Officer, GM of Pharmaceutical Headquarters & Director
Yoshihisa Fujimoto Senior Executive Officer, GM of Administration, General Affairs & Life Support Department and Director
Takuya Sakurai Executive Officer & GM of Group Corporate Planning Department
Kazunori Ogi President, Representative Director & Chief Executive Officer
Noriaki Miyata Senior Executive Officer
Poll Results

No votes yet today — be the first to share your view!

About NIHON CHOUZAI Co.,Ltd. (JPX:3341.T) Stock

Nihon Chouzai Co., Ltd. is a Japanese enterprise primarily known for operating a vast network of health insurance-compliant dispensing pharmacies throughout the country. Beyond its core retail pharmacy business, the company develops and markets generic medications, supplying them to various medical facilities and other drug retailers. It also provides diverse human resources solutions, including temporary staffing for pharmacists and recruitment services for medical doctors, licensed sales personnel, and other professionals within the healthcare industry. Additionally, Nihon Chouzai offers specialized research and study services to pharmaceutical companies and related organizations, alongside providing expert information and consulting to the broader pharmaceutical and healthcare sectors. ... A range of other services are also part of its portfolio. As of March 31, 2022, the company operated 697 stores. Established in 1980, its corporate headquarters are located in Tokyo, Japan.

Frequently Asked Questions

What is the current NIHON CHOUZAI Co.,Ltd. (3341.T) stock price?

NIHON CHOUZAI Co.,Ltd.(JPX:3341.T) stock price is $3910 in the last trading session. During the trading session, 3341.T stock reached the peak price of $23773364200 while $1314 was the lowest point it dropped to. The percentage change in 3341.T stock occurred in the recent session was --0.38% while the dollar amount for the price change in 3341.T stock was -$15.

3341.T's industry and sector of operation?

The JPX listed 3341.T is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector.

Who are the executives of 3341.T?

Toshiyuki Koyanagi | Senior Executive Officer, GM of Pharmaceutical Headquarters & Director
Yoshihisa Fujimoto | Senior Executive Officer, GM of Administration, General Affairs & Life Support Department and Director
Takuya Sakurai | Executive Officer & GM of Group Corporate Planning Department
Kazunori Ogi | President, Representative Director & Chief Executive Officer
Noriaki Miyata | Senior Executive Officer

How many employees does 3341.T have?

Number of 3341.T employees currently stands at 5864. 3341.T operates from GranTokyo North Tower, Tokyo, None 100-6737, JP.

Link for 3341.T official website?

Official Website of 3341.T is: https://www.nicho.co.jp

How do I contact 3341.T?

3341.T could be contacted at phone #81 3 6810 0800 and can also be accessed through its website. 3341.T operates from GranTokyo North Tower, Tokyo, None 100-6737, JP.

How many shares of 3341.T are traded daily?

The average number of 3341.T shares traded daily for last 3 months was 50.82K.

What is the market cap of 3341.T currently?

The market value of 3341.T currently stands at $116.82B with its latest stock price at $3910